Rentokil Initial plc (LON:RTO) has been given an average recommendation of “Buy” by the twelve analysts that are currently covering the company, MarketBeat Ratings reports. Five investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is GBX 365 ($4.77).
Several research firms have recently issued reports on RTO. Peel Hunt restated an “add” rating on shares of Rentokil Initial in a research report on Tuesday, July 31st. Numis Securities restated a “hold” rating and issued a GBX 330 ($4.31) price target on shares of Rentokil Initial in a research report on Wednesday, August 1st. Jefferies Financial Group restated a “hold” rating on shares of Rentokil Initial in a research report on Monday, August 6th. Deutsche Bank raised their price target on Rentokil Initial from GBX 320 ($4.18) to GBX 325 ($4.25) and gave the stock a “hold” rating in a research report on Friday, August 17th. Finally, JPMorgan Chase & Co. restated an “overweight” rating and issued a GBX 345 ($4.51) price target (up from GBX 211 ($2.76)) on shares of Rentokil Initial in a research report on Wednesday, October 17th.
RTO traded up GBX 4.10 ($0.05) during mid-day trading on Thursday, reaching GBX 315.30 ($4.12). The stock had a trading volume of 2,039,297 shares, compared to its average volume of 7,450,000. Rentokil Initial has a 52 week low of GBX 238.20 ($3.11) and a 52 week high of GBX 338.80 ($4.43).
Rentokil Initial plc, through its subsidiaries, provides route-based services in North America, the United Kingdom, Europe, Asia, Pacific, and rest of world. It offers a range of pest control services from rodents to flying insects, as well as to other forms of wildlife management for commercial and residential customers.
Further Reading: Trading Strategy Methods for Individual Investors
Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.